4D-725

N/A

Report date: 2025/01/26 18:50:10

Base Information

Drug Name4D-725
Drug Alias NameA1AT gene therapy (4D Molecular Therapeutics)4D-725
ClassificationBiologics
Mechanisms of ActionAlpha-1-antiproteinase modulatorsAlpha-1-antiproteinase stimulants
TargetsAlpha-1-antiproteinase
Therapy Area/IndicationsLung Diseasesalpha 1-Antitrypsin Deficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companies4d Molecular Therapeutics Inc
China Registration ClassN/A

Develop Information

Active Companies4d Molecular Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsLung Diseasesalpha 1-Antitrypsin Deficiency
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A